Grants & Funding

Small Grant


Results of the Spring 2019 Grant Cycle will be announced the first week of June.


CARRA-Arthritis Foundation Small Grant Applications to Include:

  • Project Summary/Abstract (300 word max)
  • Lay Summary (150 word max)
  • Resubmission Modification, if applicable (Download template: WORD)
  • Specific Aims (limit 1 page) (Download template: WORD)
  • Research Plan (limit 3 pages) (Download template: WORD)
  • References (no page limit) (Download template: WORD)
  • Budget Table (limit 1 page) (Download template: WORD)
  • Budget Justification (Download template: WORD)
    • Total costs salary support for Principal Investigator(s) and all Co-Investigator(s) must not exceed 50% of total project costs.
    • CARRA will allow up to 8% F&A (indirect) costs which must be incorporated into the project budget below. If indirect costs are requested, total costs for this project must not exceed $25,000.
    • Poster printing and publication costs are not allowed.
    • Travel expense requests are not permitted unless required for the conduct of the research. Travel expenses to attend meetings to present this work, for example, are not allowed.
    • Other expenses should be discussed with CARRA personnel prior to application submission.
  • NIH-formatted Biosketches for all Principal Investigator(s) and all Co-Investigator(s) (limit 5 pages per biosketch; please combine all biosketches into one PDF with the PI(s) biosketch listed first.)
  • Letters of Support
    • Required for budgets that include investigator salary/effort. Letter should be from division chief documenting that % effort is available, and confirming investigator salary. (If PI is the division chief, a letter from the Department Chairperson is required.)
    • Letters of support from collaborators, mentors and institution are highly recommended.
  • Research Assurances
  • Appendix (limit 1 attachment)

Review the detailed application checklist and instructions prior to submission. (Updated instructions coming soon!) Applicants must use the templates provided when submitting their final applications.  CARRA Staff is available to assist with the application process and to answer questions. Contact us by emailing [email protected].

APPLICATIONS NOT FOLLOWING THESE GUIDELINES WILL NOT BE CONSIDERED

The application deadline has passed.


Important Information for Small Grant Submissions

Applications due: February 15 & October 1
(Two rounds per year)

This opportunity is available to support projects in development.  New or early investigators are encouraged to apply and will be afforded special consideration.  The research project can be a pilot, continuation of ongoing research, or other projects that move forward clinical or translational research that furthers the CARRA mission. Preference will be given to research that is collaborative in nature, which leverage current CARRA network resources and/or will further develop the CARRA network.

Details:

  • There is no pre-specified number of grants available.
  • The funding limit of this grant mechanism is $25,000.
  • Salary/Effort: Letters of support are required for budgets that include investigator effort (include letter from division chief documenting that % effort is available, and confirming investigator salary). Total costs salary support for PI(s) and Co-I(s) must not exceed 50% of total project costs.
  • This is a total costs award. If indirects are requested, they must be inclusive of the maximum funding amount of $25,000. Indirects may not exceed 8%.
  • A given investigator can only receive one large or small grant per 365 day period.
  • Funds will be provided to the awardee’s institution as an unrestricted grant provided as a lump sum to a sundry account used by the PI according to the project budget.
  • The project period is one year beginning July 1.
  • If the PI is unable to complete the project, any unexpended balance must be returned to CARRA.
  • Awardees are expected to submit an abstract and attend the CARRA Annual Meeting(s) until the project is complete/final results have been presented.
  • This funding mechanism is not intended for projects that are already eligible/appropriate for extramural funding.
  • After funding decisions are determined, two small grants will be selected by CARRA to be sponsored by funding received from AOII.

Instructions:

  • Read the CARRA-Arthritis Foundation Small Grant instructions carefully. Be sure to be compliant with margins and page limits.
  • Use the document templates provided is REQUIRED. Submit your completed CARRA-Arthritis Foundation Small Grant application via the online grant submission system.
  • The next deadline for CARRA-Arthritis Foundation Small Grant Applications is February 15.

Eligibility

  • The project PI for all grants must be a current CARRA member who is up to date on membership dues and membership information (location, contact information, and membership status) is up-to-date.
  • An investigator may only receive one CARRA grant (large or small) per year (365 day period). 
  • Awardees from previous grant cycles who wish to submit grant applications for the February 2019 deadline must have all active large or small grant projects completed and have submitted a final progress report (template available on the CARRA website).
  • MD applicants must be at a faculty level to be eligible to submit proposals.
  • Pediatric Rheumatologist Members, Sponsored Voting Members, Emeritus Members, Associate Physician Members, Associate Health Care Members, and Research Coordinator Members are eligible to submit proposals.
  • Priority will be given to new and/or early investigators.
  • All grants must be submitted by or have a pediatric rheumatologist named as a Co-Investigator.
  • Fellow Members, Trainee Members, CARRA Executive Committee and Board of Directors members are not eligible.

 

Funding and Funding Period

  • Awards are total costs. Up to 8% F&A (indirect) costs are allowed, but costs must be incorporated into the project budget and not exceed the advertised award amount.
  • Publication, presentation, and travel costs should not be requested/included, unless the travel is an essential part of performing the research.
  • Salary support will be limited to a base-salary cap of $200,000 but can include payment of local fringe rates (on top of $200,000 salary cap).
  • Please review CARRA’s statement of direct and indirect support.
  • After funding decisions are determined, two small grants will be selected by CARRA to be sponsored by funding received from AOII.
  • All awards are for one year, with funding beginning July 1.
  • Applicants will be notified of funding decisions in June 2019.
  • If the project is not completed within the project period, the award recipient may request a no-cost extension (NCE) for up to 12 months.  Requests for NCEs can be made up to 90 days prior, but no less than 30 days prior, to the project period end date. An interim progress report must be submitted with the NCE Request Form, both of which are available on the CARRA website

Reporting

  • Awardees must submit a final progress report no later than 45 days after the project period end date.
  • Awardees from previous grant cycles who wish to submit grant applications for the February 2019 deadline must have all active large or small grant projects completed and have submitted a final progress report (template available on the CARRA website).
  • Timely provision of progress reports is required for future eligibility for CARRA-Arthritis Foundation grants.
  • Awardees are expected to submit abstracts to CARRA and present their findings at the CARRA Annual Scientific Meeting(s) until the project is complete/final results are presented.

Publications

  • Awardees are expected to submit a peer-reviewed abstract to a scientific meeting based on the funded project.
  • All awardees of CARRA-Arthritis Foundation funding must abide by the procedures outlined in the CARRA Publications Policy when presenting/publishing findings from their projects. This includes submitting all abstracts and manuscripts to the CARRA Publications Committee for approval prior to submission and acknowledging the support of CARRA and the Arthritis Foundation by including the following language: “The authors wish to acknowledge CARRA, and the ongoing Arthritis Foundation financial support of CARRA.” Refer to the current Publications Policy for complete details.